Status:
RECRUITING
Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring
Lead Sponsor:
Luzerner Kantonsspital
Conditions:
Intraocular Pressure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. El...
Eligibility Criteria
Inclusion
- Informed consent
- Subjects aged 18 and older
- Glaucoma patients and healthy controls
- Best corrected visual acuity \>0.1
- Astigmatism ≤ 3dpt.
- Good compliance
- Central corneal thickness (400-650μm)
- Passed certification procedure (detailed description under: Measurements and procedures)
- Therapeutic regimen unchanged throughout the past 30 days
Exclusion
- History of ocular trauma
- Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual acuity \<0.1
- Physical or mental disability interfering with self-tonometry (e.g. arthritis, Parkinson's disease)
- Dry eye disease
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- Pregnancy
- Breastfeeding
Key Trial Info
Start Date :
November 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04485897
Start Date
November 26 2020
End Date
August 1 2024
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cantonal Hospital of Lucerne
Lucerne, Switzerland, 6004